Instylla's Embrace Hydrogel System Receives FDA Approval for Tumor Treatment Instylla, Inc. has received FDA premarket approval for its Embrace Hydrogel Embolic System, providing a new treatment option for hypervascular tumors.

Instylla's Embrace Hydrogel System Receives FDA Approval for Tumor Treatment #United_States #Bedford #Interventional_Radiology #Instylla #Embrace_Hydrogel

Sean Boyle Takes the Helm as CEO of Instylla, Leading Medical Innovations Instylla, Inc. announces the appointment of Sean Boyle as CEO, bringing a wealth of experience in medical devices and a vision for driving innovative treatment solutions.

Sean Boyle Takes the Helm as CEO of Instylla, Leading Medical Innovations #USA #Bedford #Instylla #Embrace_Hydrogel #Sean_Boyle

Daniel Davis Joins Instylla's Board of Directors to Drive Innovation in Embolic Solutions Instylla, Inc. announces the appointment of Daniel Davis to its Board of Directors, bringing over 25 years of medical device expertise.

Daniel Davis Joins Instylla's Board of Directors to Drive Innovation in Embolic Solutions #USA #Bedford #Instylla #Daniel_Davis #Embrace_Hydrogel